J Liver Cancer Search

CLOSE


J Liver Cancer > Volume 16(2); 2016 > Article
Journal of Liver Cancer 2016;16(2):82-85.
DOI: https://doi.org/10.17998/jlc.16.2.82    Published online September 30, 2016.
Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis
Jin Su Kim, Su Cheol Park
Department of Internal Medicine, Korea Cancer Center Hospital, Korean Institute of Radiological and Medical Sciences, Seoul, Korea
Correspondence:  Su Cheol Park,
Email: hepapark@kcch.re.kr
Copyright ©2016 by The Korean Liver Cancer Association
Abstract
Transarterial chemoembolization (TACE) has been widely performed as a treatment for unresectable hepatocellular carcinoma (HCC). Recently extrahepatic metastasis (EHM) of HCC is increasing due to improvement of survival. Sorafenib has been generally accepted as a standard treatment in advanced HCC. However, many HCC patients with EHM are treated with TACE in real-world clinical practice because sorafenib has modest efficacy and the main cause of death in the patients with EHM is hepatic failure. In this review, the usefulness of TACE for the patients with HCC and EHM will be discussed.
Key Words: Hepatocellular carcinoma; Extrahepatic metastasis; Transarterial chemoembolization
NULL


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
1527 Gangnam Finance Plaza (FASTFIVE), 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea
Tel: +82-2-313-1900    E-mail: liver@klcsg.or.kr                

Copyright © 2019 by The Korean Liver Cancer Association. All rights reserved.

Developed in M2community

Close layer
prev next